產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
- 400-999-210024小時服務(wù)熱線
T24 [T-24] (人膀胱移行細(xì)胞癌細(xì)胞) (STR鑒定正確)
貨號:CL-0227
規(guī)格:1×10?cells/T25培養(yǎng)瓶
價格: ¥1600
生長培養(yǎng)基:McCoy’s 5A+10% FBS+1% P/S
產(chǎn)品概述
名稱 | T24 [T-24] (人膀胱移行細(xì)胞癌細(xì)胞) (STR鑒定正確) |
別稱 | T-24; T 24 |
種屬 | 人 |
生長特性 | 貼壁細(xì)胞 |
細(xì)胞形態(tài) | 上皮細(xì)胞樣 |
凍存條件 | 凍存液:55% 基礎(chǔ)培養(yǎng)基+40%FBS+5%DMSO 溫度:液氮 |
培養(yǎng)方案A(默認(rèn)) |
生長培養(yǎng)基:
培養(yǎng)條件:
氣相:空氣,95%;CO2,5%, 溫度:37℃
|
推薦傳代比例 | 1:2-1:4 |
推薦換液頻率 | 2-3次/周 |
背景描述 | T24細(xì)胞源自病人的轉(zhuǎn)移性細(xì)胞腺癌,對T24和相關(guān)細(xì)胞株有細(xì)胞毒性。T24細(xì)胞群體倍增時間為19小時,含ras(H-ras)癌基因。 |
年齡(性別) | 女性;81歲 |
組織來源 | 膀胱;移行細(xì)胞癌 |
細(xì)胞類型 | 腫瘤細(xì)胞 |
腫瘤類型 | 膀胱癌細(xì)胞 |
生物安全等級 | BSL-1 |
倍增時間 | ~20-48 hours |
致瘤性 | Yes, in hamster cheek pouch.No, in nude mice. |
抗原表達(dá)情況 | HLA A1, A3, B18, Bw35, Cw4, DRw2, Dw4 |
基因表達(dá)情況 | tumor specific antigen, HLA A1, A3, B18, Bw35, Cw4, DRw2, Dw4 |
保藏機(jī)構(gòu) | ATCC; HTB-4 DSMZ; ACC-376 |
STR鑒定
-
STR位點信息
Amelogenin X CSF1PO 10,12 D2S1338 20,23 D3S1358 16 D5S818 10,12 D7S820 10,11 D8S1179 14 D13S317 12 D16S539 9 D18S51 16,18 D19S433 13,14 D21S11 29 FGA 17,22 PentaD 11,15 PentaE 7,10 TH01 6 TPOX 8,11 vWA 17 D6S1043 11 D12S391 18 D2S441 11,15 -
STR鑒定圖
參考文獻(xiàn)
-
BCAT2 Shapes a Noninflamed Tumor Microenvironment and Induces Resistance to Anti-PD-1/PD-L1 Immunotherapy by Negatively Regulating Proinflammatory Chemokines and Anticancer Immunity(2023/01/15)
作者:Zhiyong Cai, Jinbo Chen, Zhengzheng Yu
期刊:Advanced Science
影響因子 :15.100
引用產(chǎn)品:CL-0227
-
WD repeat protein 54-mediator of ErbB2-driven cell motility 1 axis promotes bladder cancer tumorigenesis and metastasis and impairs chemosensitivity(2023/01/07)
作者:Xiaosong Wei, Beibei Wang, Zixin Wu
期刊:CANCER LETTERS
DOI:10.1016/j.canlet.2023.216058
影響因子 :9.700
引用產(chǎn)品:CL-0002 CL-0125 CL-0222 CL-0227 CL-0463 CL-0628 PM150410 PM150710 PM150910 PM151010
-
Deciphering the immunological and prognostic features of bladder cancer through platinum-resistance-related genes analysis and identifying potential therapeutic target P4HB(2023/09/18)
作者:Situ Xiong, Sheng Li, Jin Zeng
期刊:Frontiers in Immunology
DOI:10.3389/fimmu.2023.1253586
影響因子 :7.300
引用產(chǎn)品:CL-0227
-
A novel CD8+ T cell-related gene signature for predicting the prognosis and immunotherapy efficacy in bladder cancer(2023/08/14)
作者:Fei Lin, Zhibin Ke, Yuting Xue
期刊:INFLAMMATION RESEARCH
DOI:10.1007/s00011-023-01772-6
影響因子 :6.700
-
Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis.(2022/09/21)
作者:Longfei Yang, Yuwei Zhang, Yang Wang
期刊:Frontiers in Pharmacology
影響因子 :5.600
引用產(chǎn)品:CL-0002 CL-0010 CL-0052 CL-0075 CL-0109 CL-0185 CL-0222 CL-0227 CM-H019 PM150110 PM150210 PM150910
-
CUDC?101 is a potential target inhibitor for the EGFR?overexpression bladder cancer cells(2023/10/12)
作者:Zhenxing Wang, Lanxin Li, Chunhong Chu
期刊:INTERNATIONAL JOURNAL OF ONCOLOGY
影響因子 :5.200
引用產(chǎn)品:CL-0227
-
Unveiling clinical significance and tumor immune landscape of CXCL12 in bladder cancer: Insights from multiple omics analysis(2023/12/12)
作者:Zhouting Tuo, Dechao Feng, Zhiwei Jiang
期刊:Chinese Journal of Cancer Research
DOI:10.21147/j.issn.1000-9604.2023.06.12
影響因子 :5.100
引用產(chǎn)品:CL-0227
-
CDK2 and CDK4 targeted liensinine inhibits the growth of bladder cancer T24 cells(2023/07/07)
作者:Hanbing Jiang, Siying Zhu, Bin Wu
期刊:CHEMICO-BIOLOGICAL INTERACTIONS
影響因子 :5.100
引用產(chǎn)品:CL-0227
-
CRTAC1 (Cartilage acidic protein 1) inhibits cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) process in bladder cancer by downregulating Yin Yang 1 (YY1) to inactivate the TGF-β pathway(2021/11/24)
作者:Jianghua Yang, Li Fan, Xiaoxing Liao
期刊:Bioengineered
DOI:10.1080/21655979.2021.1974645
影響因子 :4.900
-
Transcriptomic profiling and risk assessment in bladder cancer: Insights from copper death-related genes(2024/05/27)
作者:Xu Wang, Long Jin, Xiaoyu Zhang
期刊:CELLULAR SIGNALLING
DOI:10.1016/j.cellsig.2024.111237
影響因子 :4.800
引用產(chǎn)品:CL-0227
-
POLR3G promotes EMT via PI3K/AKT signaling pathway in bladder cancer(2023/11/07)
作者:Hualin Chen, Lin Ma, Wenjie Yang
期刊:FASEB JOURNAL
影響因子 :4.800
引用產(chǎn)品:CL-0227
-
The oncogenic role of TFAP2A in bladder urothelial carcinoma via a novel long noncoding RNA TPRG1-AS1/DNMT3A/CRTAC1 axis(2022/11/21)
作者:Jiani He, Changming Dong, Hao Zhang, Yuanjun Jiang, Tao Liu, Xiaojun Man
期刊:CELLULAR SIGNALLING
DOI:10.1016/j.cellsig.2022.110527
影響因子 :4.800
-
A pan-cancer analysis of DDR1 in prognostic signature and tumor immunity, drug resistance(2023/04/08)
作者:Longfei Yang, Yuwei Zhang, Yifan Tang
期刊:Scientific Reports
DOI:10.1038/s41598-023-27975-9
影響因子 :4.600
引用產(chǎn)品:CL-0002 CL-0010 CL-0052 CL-0075 CL-0109 CL-0185 CL-0222 CL-0227 CM-H019 PM150110 PM150210 PM150910
-
A novel anoikis-related gene signature identifies LYPD1 as a novel therapy target for bladder cancer(2024/02/08)
作者:Zhen Song, Shikai Gui, Shuaiyun Xiao
期刊:Scientific Reports
DOI:10.1038/s41598-024-53272-0
影響因子 :4.600
引用產(chǎn)品:CL-0227
-
Identification and preliminary analysis of hub genes associated with bladder cancer progression by comprehensive bioinformatics analysis(2024/02/02)
作者:Han Wang, Junjie Liu, Yanyan Lou
期刊:Scientific Reports
DOI:10.1038/s41598-024-53265-z
影響因子 :4.600
引用產(chǎn)品:CL-0227
-
CircRPPH1 accelerates the proliferation and migration of bladder cancer via enhancing the STAT3 signaling pathway(2023/03/31)
作者:Xiao Liu, Yonghua Tong, Qiu Huang
期刊:ONCOLOGY REPORTS
影響因子 :4.200
-
TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancer(2024/02/09)
作者:Runhua Tang, Haoran Wang, Jianyong Liu
期刊:EUROPEAN JOURNAL OF MEDICAL RESEARCH
DOI:10.1186/s40001-024-01688-9
影響因子 :4.200
引用產(chǎn)品:CL-0227
-
Comprehensive analysis indicated that NDE1 is a potential biomarker for pan-cancer and promotes bladder cancer progression(2024/03/11)
作者:Peihan Wang, Jinzhuo Ning, Wu Chen
期刊:Cancer Medicine
影響因子 :4.000
引用產(chǎn)品:CL-0227
-
CENPW knockdown inhibits progression of bladder cancer through inducing cell cycle arrest and apoptosis(2024/01/01)
作者:Peng Zhang, Qian Yang, Xulong Chen
期刊:Journal of Cancer
影響因子 :3.900
引用產(chǎn)品:CL-0227
-
circCEP128 Knockdown Suppresses Bladder Cancer Progression via Regulating microRNA-515-5p/SDC1 Axis(2022/12/21)
作者:Guanghui Cao, Chan Zhang, Xiangyong Tian
期刊:Cancer Management and Research
影響因子 :3.602
引用產(chǎn)品:CL-0227
-
Rad54L promotes bladder cancer progression by regulating cell cycle and cell senescence(2022/09/07)
作者:Yinzhao Wang, Tailai Zhou, Hengxing Chen
期刊:MEDICAL ONCOLOGY
DOI:10.1007/s12032-022-01751-7
影響因子 :3.400
-
Effects of targeted Notch1 silencing on the biological processes of the T24 and 5637 cells in vitro(2021/2/21)
作者:Kewen Zheng, Xiaomin Han, Yan Su
期刊:Oncology Letters
影響因子 :2.900
引用產(chǎn)品:CL-0227
-
PC4 promotes bladder cancer progression and stemness by directly interacting with Sp1 to transcriptionally activate the Wnt5a/β-catenin pathway(2024/05/26)
作者:Benhuang Yan, Peng Luo, Heping Qiu
期刊:PATHOLOGY RESEARCH AND PRACTICE
影響因子 :2.800
引用產(chǎn)品:CL-0227
-
Gene expression profiles to analyze the anticancer and carcinogenic effects of arsenic in bladder cancer(2023/10/15)
作者:Xiaomin Han, Tengteng Zhang, Qiang Ma
期刊:American Journal of Translational Research
DOI:PMID:37969188
影響因子 :2.200
引用產(chǎn)品:CL-0227
-
The mechanism of PFK-1 in the occurrence and development of bladder cancer by regulating ZEB1 lactylation(2024/03/13)
作者:Rong Wang, Fei Xu, Zhengjia Yang
期刊:BMC Urology
DOI:10.1186/s12894-024-01444-5
影響因子 :2.000
引用產(chǎn)品:CL-0227
-
Hsa_circ_0008035 Knockdown Inhibits Bladder Cancer Progression through miR-1184/RAP2B Axis(2023/03/23)
作者:Yang Fu, Kun Liu, Xi Jiang
期刊:UROLOGIA INTERNATIONALIS
影響因子 :1.600
-
Elevated 8-oxo-7,8-dihydro-2′-deoxyguanosine in genome of T24 bladder cancer cells induced by halobenzoquinones(2017/5/22)
作者:Tian Xu, Junfa Yin, Shaokun Chen
期刊:Journal Of Environmental Sciences-China
影響因子 :0.000
引用產(chǎn)品:CL-0227
FAQs
Q:{{item.question}}
A:
產(chǎn)品資料
識別碼示意圖